Corbus Pharmaceuticals Holdings, Inc. (CRBP) Net margin 2016–2021
Corbus Pharmaceuticals Holdings, Inc. (CRBP) net profit margin by fiscal year — reported net income divided by reported revenue.
-5176.4%FY2021 · since FY2016: -1046.3% → -5176.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -5176.4% | -2350.3 pp |
| FY2020 | -2826.1% | -2628.4 pp |
| FY2019 | -197.7% | +956.8 pp |
| FY2018 | -1154.5% | +174.2 pp |
| FY2017 | -1328.6% | -282.4 pp |
| FY2016 | -1046.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice